Kansas Bioscience Authority

leaves in petri dish

The Kansas Bioscience Authority is focusing resources in sectors that Kansas has national leadership and expertise, including animal health, bioenergy, biomaterials, human health and plant biology.

KBA's Cancer Fighting Cures initiative is an example of a statewide effort to improve the quality of cancer-related research and care. The initiative seeks to leverage the state's excellence in pharmaceutical research to spur the commercialization of cancer drugs and boost Kansans' access to the most advanced therapies.

This groundbreaking clinical trial was able to open in 2011 because of the KBA's essential support for The Learning Collaborative which brings together proven expertise in blood cancer and drug discovery and development in order to rapidly advance high-impact projects. The collaborative was formed in June 2010 in an effort to bridge what is called the "valley of death" for drugs under development.

Last modified: May 23, 2012

KBA logoThe KBA is the state's largest-ever commitment to expanding Kansas' research capabilities, promoting innovation, and encouraging company formation that will create high-paying jobs for generations to come.

The KBA is leveraging its funds to attract additional federal and private-sector support that could boost the total investment in bioscience in the state to more than $5 billion.

The KBA was created by the Kansas Economic Growth Act of 2004 with the sole purpose of advancing Kansas' leadership in bioscience.

Learn more about KBA